# Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA

> **NCT04166149** · — · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 140 (actual)

## Conditions studied

- Transplant;Failure,Kidney
- Transplant; Failure, Pancreas
- Rejection Acute Renal
- Rejection Acute Pancreas

## Interventions

- **DIAGNOSTIC_TEST:** dd-cfDNA Blood Test

## Key facts

- **NCT ID:** NCT04166149
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-09-06
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04166149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04166149, "Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04166149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*